Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature

被引:13
|
作者
Rizzo, Angelo Cascio [1 ]
Giussani, Giuditta [1 ]
Agostoni, Elio Clemente [1 ]
机构
[1] ASST Grande Osped Metropolitano Niguarda, Neurol & Stroke Unit, Milan, Italy
关键词
Stroke; Vaccine-induced immune thrombotic thrombocytopenia; COVID-19; vaccine; Large vessel occlusion; Thrombotic thrombocytopenia;
D O I
10.1159/000524290
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a prothrombotic syndrome observed after adenoviral vector-based vaccines for severe acute respiratory syndrome coronavirus 2. It is characterized by thrombocytopenia, systemic activation of coagulation, extensive venous thrombosis, and anti-platelet factor 4 antibodies. Arterial thrombosis is less common and mainly affects the aorta, peripheral arteries, heart, and brain. Several cases of ischemic stroke have been reported in VITT, often associated with large vessel occlusion (LVO). Here, we describe a case of ischemic stroke with LVO after Ad26.COV2.S vaccine, then we systematically reviewed the published cases of ischemic stroke and VITT following COVID-19 vaccination. Methods: We describe a 58-year-old woman who developed a thrombotic thrombocytopenia syndrome with extensive splanchnic vein thrombosis and ischemic stroke due to right middle cerebral artery (MCA) occlusion, 13 days after receiving Ad26.COV2.S vaccination. Then, we performed a systematic review of the literature until December 3, 2021 using PubMed and EMBASE databases. The following keywords were used: ( "COVID-19 vaccine ") AND ( "stroke "), ( "COVID-19 vaccine ") AND ( "thrombotic thrombocytopenia "). We have selected all cases of ischemic stroke in VITT. Results: Our study included 24 patients. The majority of the patients were females (79.2%) and younger than 60 years of age (median age 45.5 years). Almost all patients (96%) received the first dose of an adenoviral vector-based vaccine. Ischemic stroke was the presenting symptom in 18 patients (75%). Splanchnic venous thrombosis was found in 10 patients, and cerebral venous thrombosis in 5 patients (21%). Most patients (87.5%) had an anterior circulation stroke, mainly involving MCA. Seventeen patients (71%) had an intracranial LVO. We found a high prevalence of large intraluminal thrombi (7 patients) and free-floating thrombus (3 patients) in extracranial vessels, such as the carotid artery, in the absence of underlying atherosclerotic disease. Acute reperfusion therapy was performed in 7 of the 17 patients with LVO (41%). One patient with a normal platelet count underwent intravenous thrombolysis with alteplase, while 6 patients underwent mechanical thrombectomy. A malignant infarct occurred in 9 patients and decompressive hemicraniectomy was performed in 7 patients. Five patients died (21%). Conclusion: Our study points out that, in addition to cerebral venous thrombosis, adenoviral vector-based vaccines also appear to have a cerebral arterial thrombotic risk, and clinicians should be aware that ischemic stroke with LVO, although rare, could represent a clinical presentation of VITT.
引用
收藏
页码:722 / 734
页数:13
相关论文
共 50 条
  • [31] Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series
    Mendes-de-Almeida, Daniela P.
    Nunes de Oliveira, Patricia Mouta
    Gomes Porto, Victor Bertollo
    Pedro, Renata Saraiva
    Gomes Takey, Paulo Roberto
    Lignani, Leticia Kegele
    Teixeir, Gabriellen Vitiello
    Pereira, Taina dos Santos
    Abreu, Debora Lima
    Xavier, Janaina Reis
    de Castro, Thalita da Matta
    de Amorim Filho, Luiz Melo
    de Sousa Maia, Maria de Lourdes
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [32] Vaccine-induced immune thrombotic thrombocytopenia
    Rodriguez, Joaquin Navarro
    Rosado, Horacio Garcia-Delgado
    Villar, Rosario Amaya
    MEDICINA INTENSIVA, 2024, 48 (04) : 242 - 243
  • [33] COVID-19 VACCINE-INDUCED THROMBOCYTOPENIA
    Tirado-Polo, Francisco
    Day, Christopher
    CHEST, 2021, 160 (04) : 10A - 10A
  • [34] Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review
    Ahmed, Syed Hassan
    Shaikh, Taha Gul
    Waseem, Summaiyya
    Qadir, Nashwa Abdul
    Yousaf, Zohaib
    Ullah, Irfan
    ANNALS OF MEDICINE AND SURGERY, 2022, 73
  • [35] COVID-19 mRNA-1273 vaccine induces production of vaccine-induced immune thrombotic thrombocytopenia antibodies
    Padmanabhan, Anand
    Kanack, Adam J.
    Kaplan, Robert B.
    Sangli, Swathi
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E223 - E225
  • [36] Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
    Kim, Ah Young
    Woo, Wongi
    Yon, Dong Keon
    Lee, Seung Won
    Yang, Jae Won
    Kim, Ji Hong
    Park, Seoyeon
    Koyanagi, Ai
    Kim, Min Seo
    Lee, Sungsoo
    Shin, Jae Il
    Smith, Lee
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 119 : 130 - 139
  • [37] Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies
    Chen, Po-Wei
    Tsai, Zong-Yun
    Chao, Ting-Hsing
    Li, Yi-Heng
    Hou, Charles Jia-Yin
    Liu, Ping-Yen
    ACTA CARDIOLOGICA SINICA, 2021, 37 (04) : 355 - 364
  • [38] Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report
    Al Rawahi, Bader
    BaTaher, Hashem
    Jaffer, Zoheb
    Al-Balushi, Aya
    Al-Mazrouqi, Asma
    Al-Balushi, Noof
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (06)
  • [39] COVID vaccine-induced immune thrombotic thrombocytopenia: Rare but relevant
    Greinacher, Andreas
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 105 : 20 - 22
  • [40] COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): State of the Art
    Calcaterra, Giuseppe
    Bassareo, Pier Paolo
    De Gregorio, Cesare
    Barilla, Francesco
    Romeo, Francesco
    Mehta, Jawahar L.
    CURRENT CARDIOLOGY REVIEWS, 2022, 18 (05) : 11 - 17